AASLD25 Poster Presentation: Phase 1, Single-Ascending Dose Results from the PHIN-001® Study of PHIN-214 in Compensated and Decompensated Patients with Cirrhosis. – PharmaIN Corporation

Post navigation

Previous PostPharmaIN Corporation Showcases Phase 1 Single-Ascending Dose Results from PHIN-001 Study of PHIN-214 in Patients with Compensated and Decompensated Cirrhosis at the AASLD, The Liver meeting® 2025

Related Posts

Contact Us
Financial Conflict of Interest Policy

Copyright © 2025-26 PharmaIN Corp. All Rights Reserved